Application of hypothetical strategies in acute pain
Pharmaceutical Statistics · 2024
DOI: 10.1002/pst.2359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2024. Verfasst von Jinglin Zhong und 1 weiteren Autor:innen. Beteiligte Einrichtung: Date Science, Sumitomo Pharma America, Marlborough, Massachusetts, USA. Hauptthemen laut MEDLINE: Acute Pain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Since the publication of ICH E9 (R1), “Addendum to statistical principles for clinical trials: on choosing appropriate estimands and defining sensitivity analyses in clinical trials,” there has been a lot of debate about the hypothetical strategy for handling intercurrent events. Arguments against the hypothetical strategy are twofold: (1) the clinical question has limited clinical/regulatory interest; (2) the estimation may need strong statistical assumptions. In this article, we provide an example of a hypothetical strategy handling use of rescue medications in the acute pain setting. We argue that the treatment effect of a drug that is attributable to the treatment alone is the clinical question of interest and is important to regulators. The hypothetical strategy is important when developing non‐opioid treatment as it estimates the treatment effect due to treatment during the pre‐specified evaluation period whereas the treatment policy strategy does not. Two widely acceptable and non‐controversial clinical inputs are required to construct a reasonable estimator. More importantly, this estimator does not rely on additional strong statistical assumptions and is considered reasonable for regulatory decision making. In this article, we point out examples where estimators for a hypothetical strategy can be constructed without any strong additional statistical assumptions besides acceptable clinical inputs. We also showcase a new way to obtain estimation based on disease specific clinical knowledge instead of strong statistical assumptions. In the example presented, we clearly demonstrate the advantages of the hypothetical strategy compared to alternative strategies including the treatment policy strategy and a composite variable strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Date Science, Sumitomo Pharma America, Marlborough, Massachusetts, USA.
- Department of Biometrics, AstraZeneca, 1 Medimmune Way, Gaithersburg, MD.
ORCID-Profile: Jinglin Zhong
Zitieren
APA
Zhong, J., & Petullo, D. (2024). Application of hypothetical strategies in acute pain. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2359
Vancouver
Zhong J, Petullo D. Application of hypothetical strategies in acute pain. Pharmaceutical Statistics. 2024. doi:10.1002/pst.2359
BibTeX
@article{Zhong2024,
author = {Zhong, Jinglin and Petullo, David},
title = {Application of hypothetical strategies in acute pain},
journal = {Pharmaceutical Statistics},
year = {2024},
doi = {10.1002/pst.2359}
}
EUVIMED